Neurological abnormalities in a knock-in mouse model of Huntington's disease - PubMed (original) (raw)
. 2001 Jan 15;10(2):137-44.
doi: 10.1093/hmg/10.2.137.
Affiliations
- PMID: 11152661
- DOI: 10.1093/hmg/10.2.137
Neurological abnormalities in a knock-in mouse model of Huntington's disease
C H Lin et al. Hum Mol Genet. 2001.
Abstract
Mice representing precise genetic replicas of Huntington's disease (HD) were made using gene targeting to replace the short CAG repeat of the mouse Huntington's disease gene homolog (HDH:) with CAG repeats within the length range found to cause HD in humans. Mice with alleles of approximately 150 units in length exhibit late-onset behavioral and neuroanatomic abnormalities consistent with HD. These symptoms include a motor task deficit, gait abnormalities, reactive gliosis and the formation of neuronal intranuclear inclusions predominating in the striatum. This model differs from previously described HDH: knock-ins by its method of construction, longer repeat length and more severe phenotype. To our knowledge, this is the first knock-in mouse model of HD to show increased glial fibrillary acidic protein immunoreactivity in the striatum, suggesting that these mice have neuronal injury similar to that found early in the course of HD. These mice will serve as useful reagents in experiments designed to reveal the molecular nature of neuronal dysfunction underlying HD.
Similar articles
- Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
Reddy PH, Charles V, Williams M, Miller G, Whetsell WO Jr, Tagle DA. Reddy PH, et al. Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1035-45. doi: 10.1098/rstb.1999.0456. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434303 Free PMC article. - Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.
Menalled LB, Sison JD, Dragatsis I, Zeitlin S, Chesselet MF. Menalled LB, et al. J Comp Neurol. 2003 Oct 6;465(1):11-26. doi: 10.1002/cne.10776. J Comp Neurol. 2003. PMID: 12926013 - Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice.
Lloret A, Dragileva E, Teed A, Espinola J, Fossale E, Gillis T, Lopez E, Myers RH, MacDonald ME, Wheeler VC. Lloret A, et al. Hum Mol Genet. 2006 Jun 15;15(12):2015-24. doi: 10.1093/hmg/ddl125. Epub 2006 May 10. Hum Mol Genet. 2006. PMID: 16687439 - Polyglutamine pathogenesis.
Ross CA, Wood JD, Schilling G, Peters MF, Nucifora FC Jr, Cooper JK, Sharp AH, Margolis RL, Borchelt DR. Ross CA, et al. Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1005-11. doi: 10.1098/rstb.1999.0452. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434299 Free PMC article. Review. - The use of transgenic and knock-in mice to study Huntington's disease.
Hickey MA, Chesselet MF. Hickey MA, et al. Cytogenet Genome Res. 2003;100(1-4):276-86. doi: 10.1159/000072863. Cytogenet Genome Res. 2003. PMID: 14526189 Review.
Cited by
- Age-dependent Powassan virus lethality is linked to glial cell activation and divergent neuroinflammatory cytokine responses in a murine model.
Mladinich MC, Himmler GE, Conde JN, Gorbunova EE, Schutt WR, Sarkar S, Tsirka S-AE, Kim HK, Mackow ER. Mladinich MC, et al. J Virol. 2024 Aug 20;98(8):e0056024. doi: 10.1128/jvi.00560-24. Epub 2024 Aug 1. J Virol. 2024. PMID: 39087762 Free PMC article. - HAP40 modulates mutant Huntingtin aggregation and toxicity in Huntington's disease mice.
Chen L, Qin Y, Guo T, Zhu W, Lin J, Xing T, Duan X, Zhang Y, Ruan E, Li X, Yin P, Li S, Li XJ, Yang S. Chen L, et al. Cell Death Dis. 2024 May 14;15(5):337. doi: 10.1038/s41419-024-06716-4. Cell Death Dis. 2024. PMID: 38744826 Free PMC article. - The contribution of preclinical magnetic resonance imaging and spectroscopy to Huntington's disease.
Pérot JB, Brouillet E, Flament J. Pérot JB, et al. Front Aging Neurosci. 2024 Feb 13;16:1306312. doi: 10.3389/fnagi.2024.1306312. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38414634 Free PMC article. Review. - Selective Vulnerability to Neurodegenerative Disease: Insights from Cell Type-Specific Translatome Studies.
Jackson WS, Bauer S, Kaczmarczyk L, Magadi SS. Jackson WS, et al. Biology (Basel). 2024 Jan 23;13(2):67. doi: 10.3390/biology13020067. Biology (Basel). 2024. PMID: 38392286 Free PMC article. Review. - Branched-chain keto acids promote an immune-suppressive and neurodegenerative microenvironment in leptomeningeal disease.
Khaled ML, Ren Y, Kundalia R, Alhaddad H, Chen Z, Wallace GC, Evernden B, Ospina OE, Hall M, Liu M, Darville LNF, Izumi V, Chen YA, Pilon-Thomas S, Stewart PA, Koomen JM, Corallo SA, Jain MD, Robinson TJ, Locke FL, Forsyth PA, Smalley I. Khaled ML, et al. bioRxiv [Preprint]. 2023 Dec 18:2023.12.18.572239. doi: 10.1101/2023.12.18.572239. bioRxiv. 2023. PMID: 38187773 Free PMC article. Preprint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases